Yvette Newbatt
Papers
1
Total Citations
16
H-Index
1
About
Yvette Newbatt is a distinguished chemical biologist whose work has significantly advanced the field of high-throughput screening for kinase inhibitors. Her research focuses on the development of robust assay platforms to identify small molecule modulators of protein kinases, particularly those implicated in cancer. Newbatt's most cited paper, "High-Throughput Screening Assay for Identification of Small Molecule Inhibitors of Aurora2/STK15 Kinase" (2004, 16 citations), exemplifies her expertise in designing and validating cellular and biochemical assays. This work provided a critical tool for discovering inhibitors of Aurora2, a key mitotic kinase often overexpressed in tumors, thereby contributing to the early pipeline of targeted cancer therapeutics. Beyond this landmark study, Newbatt has been instrumental in establishing screening methodologies for a range of kinases, enabling the identification of novel chemical probes and drug leads. Her meticulous approach to assay development and her contributions to collaborative drug discovery projects have made her a respected figure in the chemical biology community. Through her efforts, Newbatt has helped bridge the gap between basic kinase biology and the development of potential treatments for cancer and other diseases.
Research Focus
Key Achievements
Top Papers
- 1